In vitro activity of the active metabolite of prulifloxacin (AF 3013) compared with six other fluoroquinolones.
Prats
G
G
Servei de Microbiologia, Hospital de la Santa Creu i Sant Pau, Avenida Sant Antoni Ma Claret, 167, 08025 Barcelona, Spain. gprats@cs.vhebron.es
Roig
C
C
Miró
E
E
Navarro
F
F
Mirelis
B
B
D000890:Anti-Infective Agents / Q000378:metabolism* / Q000494:pharmacology*; D004148:Dioxolanes / Q000378:metabolism* / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D024841:Fluoroquinolones; D006090:Gram-Negative Bacteria / Q000187:drug effects*; D006094:Gram-Positive Bacteria / Q000187:drug effects*; D006801:Humans; D008826:Microbial Sensitivity Tests; D010879:Piperazines / Q000378:metabolism* / Q000494:pharmacology*; D015363:Quinolones / Q000378:metabolism* / Q000494:pharmacology*
D000890:Anti-Infective Agents; D004148:Dioxolanes; D024841:Fluoroquinolones; D010879:Piperazines; D015363:Quinolones; C074191:prulifloxacin